The Week

Walmart (WMT) slipped 0.59% this week to close at $103.09, while the S&P 500 rose 0.49%, leaving the stock about 1.08 percentage points behind the benchmark. The week started strong and faded into Thursday. On Monday (Aug 24) the stock rallied to a weekly high of $106.595 before closing at $106.49; Tuesday and Wednesday edged lower, and Thursday (Aug 27) accelerated down to an intraday low of $102.27, closing at $102.63. Friday (Aug 28) regained some ground to $103.09 but stayed below the week’s open. Range for the week was about 4.15%, and daily turnover averaged roughly 28.1 million shares, above the two-month median.

Key Events

The heaviest news flow ran from Aug 26 to Aug 29, centred on the post-Q2 valuation debate and the opioid settlement. On Tuesday (Aug 26), several outlets highlighted Walmart’s roughly 37x valuation, noting it had become more expensive than Nvidia, while traffic looked soft; the same day the company added contactless payment across US stores and Sam’s Club and posted the transcript of its Q2 FY2027 buy-side investor follow-up call. Wednesday (Aug 27) turned to institutional positioning, with Elevation Point Wealth Partners taking a new stake of about $20.56 million and Compass Financial Management, TRB Wealth Management and others disclosing new buys. On Thursday (Aug 28) EVP Daniel Danker disclosed selling about $10.96 million worth of common shares. After the close on Friday, the US Justice Department announced Walmart had settled the opioid civil litigation, with the company calling the amount immaterial and already accrued as of July 31; later reports confirmed a $50 million payment. The settlement news helped sentiment into Saturday, with some coverage turning to whether Walmart can return to a $1 trillion valuation.

Analyst Ratings

Coverage stands at 43 institutions: 27 rate it buy, 10 overweight, 5 hold and 1 underweight, with no sell or no-opinion ratings. The consensus recommendation is buy, with a consensus target of $127.725, about 23.9% above the spot price of $103.09. Targets are wide, from a low of $81 to a high of $155, showing meaningful dispersion among analysts. Within the consumer retail industry, Walmart ranks first by rating out of nine names, and its 43 covering institutions sit above the industry median of 28.

The Week Ahead

Next week brings a heavy macro calendar. Monday (Aug 31) has the Dallas Fed manufacturing business activity index, with a prior reading of 1.3. Tuesday (Sept 1) includes the S&P Global manufacturing PMI final, ISM manufacturing PMI and JOLTS job openings; ISM stands at a prior 55.6 with a 55.2 estimate, and JOLTS at 7.359 million prior versus 7.3 million expected. Wednesday (Sept 2) adds ADP private payrolls, factory orders and EIA crude inventory data. On the company side, the next report is Q3 FY2027 earnings scheduled for Nov 19 pre-market, with consensus estimates of $0.6338 EPS and $187 billion in revenue. Near term, follow-through from the opioid settlement and the continuing valuation debate may keep short-term sentiment active.

In Short

Walmart finished the week lower and lagged the market, but the flow of information was not one-directional. The analyst backdrop remains supportive, with a buy consensus and a target about 23.9% above the current price, plus a top industry ranking. Valuation sits at roughly 37x P/E and 8.35x P/B, high enough that comparisons with Nvidia have become a talking point. The latest trading day’s flow shows large and medium lots as net buyers while small lots were net sellers, suggesting incremental buying alongside profit-taking. What to watch from here is whether the market continues to pay around 37x earnings, and whether the Q3 report in November delivers enough incremental growth to match the current price.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.